Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.

Volpe M, Tocci G.

Drugs Aging. 2013 Dec;30(12):987-98. doi: 10.1007/s40266-013-0130-8. Review.

PMID:
24170236
2.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
3.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
4.

Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.

Heagerty AM, Mallion JM.

Drugs Aging. 2009;26(1):61-76. doi: 10.2165/0002512-200926010-00005.

PMID:
19102515
5.

Olmesartan medoxomil for the treatment of hypertension in children and adolescents.

Tocci G, Volpe M.

Vasc Health Risk Manag. 2011;7:177-81. doi: 10.2147/VHRM.S11672. Epub 2011 Mar 31. Review.

6.

Olmesartan medoxomil: a review of its use in the management of hypertension.

Scott LJ, McCormack PL.

Drugs. 2008;68(9):1239-72. Review.

PMID:
18547134
7.

Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Omboni S, Malacco E, Mallion JM, Fabrizzi P, Volpe M.

High Blood Press Cardiovasc Prev. 2014 Mar;21(1):1-19. doi: 10.1007/s40292-013-0037-9. Epub 2014 Jan 17. Review.

PMID:
24435506
8.

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

Malacco E, Omboni S, Mallion JM, Volpe M; ESPORT Study Group.

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.

PMID:
23430666
10.

Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin Drug Investig. 2007;27(8):545-58.

PMID:
17638395
11.
12.

Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.

Tocci G, Paneni F, Passerini J, Volpe M.

Expert Opin Pharmacother. 2012 Dec;13(18):2687-97. doi: 10.1517/14656566.2012.745510. Epub 2012 Nov 21. Review.

PMID:
23170911
13.

Clinical efficacy and tolerability of olmesartan.

Brunner HR.

Clin Ther. 2004;26 Suppl A:A28-32. Review.

PMID:
15291377
15.

Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.

Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Waki H, Maeda M, Ogawa H, Kim-Mitsuyama S.

Atherosclerosis. 2014 Sep;236(1):101-7. doi: 10.1016/j.atherosclerosis.2014.06.016. Epub 2014 Jun 26.

PMID:
25016364
16.
18.

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.

Mallion JM, Omboni S, Barton J, Van Mieghem W, Narkiewicz K, Panzer PK, Puig JG, Stefanadis C, Zweiker R; Study Group.

Blood Press Suppl. 2011 Apr;1:3-11. doi: 10.3109/08037051.2010.532332. Epub 2010 Nov 23.

PMID:
21091270
19.

Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.

da Silva PM.

Clin Drug Investig. 2010;30(9):625-41. doi: 10.2165/11538440-000000000-00000. Review.

PMID:
20626210
20.

Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.

Wang L, Zhao JW, Liu B, Shi D, Zou Z, Shi XY.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):335-44. doi: 10.2165/11597390-000000000-00000. Review.

PMID:
22920046

Supplemental Content

Support Center